vTv Therapeutics Inc. filed its 10-K on Mar 06, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
26.98 USD | -3.29% | +5.81% | +134.62% |
Mar. 14 | VTv Therapeutics Inc. Announces Board Changes | CI |
Mar. 13 | VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+134.62% | 67.88M | |
-2.54% | 102B | |
+2.33% | 96.09B | |
+2.13% | 22.28B | |
-17.07% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.83% | 16.09B | |
+6.38% | 13.83B | |
+32.58% | 11.97B |
- Stock Market
- Equities
- VTVT Stock
- News vTv Therapeutics Inc.
- VTv Therapeutics Inc. Auditor Raises 'Going Concern' Doubt